Literature DB >> 1831750

Cyclin B mRNA depletion only transiently inhibits the Xenopus embryonic cell cycle.

D L Weeks1, J A Walder, J M Dagle.   

Abstract

The control of the cell cycle is dependent on the ability to synthesize and degrade proteins called cyclins. When antisense oligonucleotides are used to deplete Xenopus embryos of mRNA encoding cyclin B protein, embryonic cleavage is inhibited. Surprisingly, after missing several rounds of cleavage, the cell cycle and cell division resumes. These studies indicate that the early embryonic cell cycle can proceed with undetectable levels of cyclin B encoding mRNA. In contrast, other events of normal development, including the activation of embryonic transcription and gastrulation, are inhibited.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831750     DOI: 10.1242/dev.111.4.1173

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  5 in total

1.  A dependent pathway of cytoplasmic polyadenylation reactions linked to cell cycle control by c-mos and CDK1 activation.

Authors:  S Ballantyne; D L Daniel; M Wickens
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

2.  Targeted elimination of zygotic messages in Xenopus laevis embryos by modified oligonucleotides possessing terminal cationic linkages.

Authors:  J M Dagle; J L Littig; L B Sutherland; D L Weeks
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

3.  Understanding oligonucleotide-mediated inhibition of gene expression in Xenopus laevis oocytes.

Authors:  C Bailey; D L Weeks
Journal:  Nucleic Acids Res       Date:  2000-03-01       Impact factor: 16.971

4.  Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation.

Authors:  J M Dagle; D L Weeks
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

5.  Synergistic action of Drosophila cyclins A and B during the G2-M transition.

Authors:  J A Knoblich; C F Lehner
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.